The Food and Drug Administration has approved a Juvederm product for lip augmentation, according to the manufacturer.
In an Oct. 1 press release, Allergan announced that Juvederm Ultra XC had been approved for “injection into the lips and perioral area for lip augmentation in adults over the age of 21.”
The product is described as a smooth gel formulation made up of a modified form of hyaluronic acid; it also contains lidocaine. In clinical studies, 79% of participants “showed a meaningful improvement in lip fullness” 3 months after treatment, the company said, and more than 78% “reported an improvement in their overall satisfaction with the look and feel of their lips” 1 year after treatment.